Billions of people around the world lack access to a proper diagnostic because they live too far from a clinic or simply can’t afford it. The standard test throughout the world for patients that comes with fever and suspicion of bacterial infection is a blood count. Existing methods return results in 24 to 72 hours.
The delayed diagnosis causes over-treatment with antibiotics. An unnecessary treatment causes the development of AMR – Antimicrobial resistance, poor treatment, and worsening of the patient’s condition. No solution today is accurate, accessible and affordable enough to allow these lab-quality tests through real-time blood tests where ever is needed.
EfA’s product, the RevDx. answers this need. The RevDx (Revolutionary Diagnostics), is a mobile, portable, handheld, end-point solution that includes an innovative method to perform an automatic computerized “microscopy-like” inspection, including a whole blood sampling and an automatic diagnosis of blood count and other applications to be followed.
The product is an easy-to-operate, based on a finger prick, and does not need laboratory conditions and specific preparations. For example, a patient will be able to make a real-time informed decision about the use of antibiotic treatment This product will be an essential device for every point-of-need around the world.